Lunai Bioworks LNAI
NASDAQ LNAI
$0.54 +0.07 (+13.94%)
As of: Oct 20, 2026 · 2:22 PM EDT

Lunai Bioworks (LNAI) Long-Term Debt Repayments (2016 - 2022)

Updated

Lunai Bioworks' Long-Term Debt Repayments was $222,167 in fiscal Q3 2022 (quarter ended Mar 31, 2022), up 22.2% from $181,794 a year earlier.

Analysis

Lunai Bioworks (LNAI) Long-Term Debt Repayments (2016 - 2022) Analysis & Trends

On a trailing twelve-month basis, Lunai Bioworks' Long-Term Debt Repayments was $1.83 million through Mar 31, 2022, down 40.7% year-over-year; for FY2020 (ended Jun 30, 2020), it came in at $272,700.

  • The fiscal Q3 2022 figure marks the highest quarterly Long-Term Debt Repayments since fiscal Q1 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,146.31 Bn 1,114.90 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 624.12 Bn 542.65 Bn 17.26 Bn 1.00 Mn
3 AbbVie 511.63 Bn 484.74 Bn 12.70 Bn 2.00 Bn
4 Merck 365.93 Bn 320.31 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 297.56 Bn 261.55 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.26 Bn 234.95 Bn 12.86 Bn 2.46 Bn
7 Amgen 234.85 Bn 190.25 Bn 7.24 Bn -
8 Gilead Sciences 194.45 Bn 168.65 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn -
10 Lunai Bioworks 1.68 Mn -3.07 Mn 20,942.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 222,167.00
Mar 31, 2021 181,794.00
Sep 30, 2017 1.56 Mn
Sep 30, 2016 -138,070.00
API Access

Lunai Bioworks Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=LNAI&period=max&api_key=YOUR_API_KEY